Sharad Sharma

Company: Boehringer Ingelheim / SUNY, Buffalo

Job title: Principal Scientist - NBE-PK Biotherapeutics Discovery Reearch / Postdoctoral Associate

Seminars:

Quantitative Evaluation of Relation Between Antigen Expression & ADC Exposure in Solid Tumours 12:30 pm

Preclinical investigation of the effect of target expression level on ADC exposure in cancer cells and tumours using anti-HER2 Trastuzumab-VC-MMAE tool ADC Evaluate the usage of cell level and in-vivo mechanistic ADC PK model to characterise preclinical data and the establishment of a quantitative relationship between antigen expression level and ADC exposure in a tumour…Read more

day: Track B - Day 2